Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd

Remdesivir, Oseltamivir phosphate, Arbidol HCl (Umifenovir HCl), Iohexol, Iopromide, Ioversol, Iopamidol, Iodixanol,Iomeprol, Gadobenate Dimeglumine, Gadopentetate monomeglumine, Fipronil, Calcitrol, Virginiamycin, Bicalutamide, Abiraterone acetate, Nepafenac, Vitamin D3,Sodium Dibunate, Mycophenolate mofetil, Mycophenolate Sodium (APIs,Intermediates,Biochemicals)

Product Certification

Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd

Country:

China (Mainland)

Business Type:Trading Company

Diamond
supplier

Contacts

Fax:

URL: http://www.jlpharms.com

Province/state: Zhejiang

City: Hangzhou

Street:Rm A606, Fuyi Center, jianqiao street, Jianggan Area

E-MAIL Supplier Clike here

lower price CAS NO.417716-92-8

Min.Order: 0
Payment Terms:
Available Specifications:

Product Details

Keywords

Lenvatinib
6-Quinolinecarboxamide, 4-(3-chloro-4-(((cyclopropylamino)carbonyl)amino)phenoxy)-7-methoxy-
6-Quinolinecarboxamide, 4-(3-chloro-4-(((cyclopropylamino)carbonyl)amino)phenoxy)-7-methoxy-

Quick Details

ProName: Lenvatinib cas
CasNo: 417716-92-8
Molecular Formula: C21H19ClN4O4
ProductionCapacity: /
Purity: 99
LimitNum: 0

Superiority

Details

Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.